Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR).
Tenenbaum A, Fisman EZ, Motro M
Cardiovasc Diabetol 2003 Mar 23, 2:4
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Review    
A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease
Fisman EZ, Tenenbaum A
Cardiovascular Diabetology 2009, 8:38 (20 July 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [1 comment]
2.


Original investigation    
Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
Tenenbaum A, Boyko V, Fisman EZ, Goldenberg I, Adler Y, Feinberg MS, Motro M, Tanne D, Shemesh J, Schwammenthal E, Behar S
Cardiovascular Diabetology 2008, 7:18 (19 June 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
3.


Review    
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Tenenbaum A, Fisman EZ, Motro M, Adler Y
Cardiovascular Diabetology 2006, 5:20 (26 September 2006)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
4.


Review    
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
Tenenbaum A, Motro M, Fisman EZ
Cardiovascular Diabetology 2005, 4:14 (16 September 2005)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central] [1 comment]
5.


Editorial    
Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
Tenenbaum A, Fisman EZ
Cardiovascular Diabetology 2004, 3:10 (1 December 2004)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
6.


Review    
Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: The pleiotropic effects of folate supplementation
Hayden MR, Tyagi SC
Nutrition Journal 2004, 3:4 (10 May 2004)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
7.


Original investigation    
Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus
Tenenbaum A, Fisman EZ, Schwammenthal E, Adler Y, Benderly M, Motro M, Shemesh J
Cardiovascular Diabetology 2003, 2:14 (23 November 2003)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
8.


Hypothesis    
Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof
Fisman EZ, Motro M, Tenenbaum A
Cardiovascular Diabetology 2003, 2:11 (12 September 2003)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 1 article in PubMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.